Samsung Bioepis Humira Biosimilar Wins FDA Approval
Subcutaneous CT-P13 Injection Evaluated for Safety & Efficacy of in RA Patients
Ixekizumab vs. Adalimumab for PsA: How Do They Compare?
FDA Approves Risankizumab, Adds Stronger Warning to Sleep Medications
British Columbia Will Be First Canadian Province to Switch Patients to Biosimilars
Ixekizumab Promising for Non-Radiographic Axial SpA; Plus FDA Approves Belimumab for Pediatric Lupus
Common Characteristics in RA Patients Who Don’t Respond to Biologics
IV Meloxicam Stalls at FDA; Plus Health Canada Approves Risankizumab for Plaque Psoriasis
Health Canada Approves Certolizumab Pegol & NICE Issues Guidance for Certolizumab Pegol
- 1
- 2
- 3
- …
- 30
- Next Page »